| Completed | Evaluating Technologies for Point-of-Care Blood Collections by Patients Healthy | N/A | 2024-10-29 |
| Withdrawn | Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19 COVID-19 | Phase 2 / Phase 3 | 2023-01-01 |
| Withdrawn | Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT) Mild to Moderate COVID-19 | Phase 3 | 2021-09-01 |
| Completed | Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 SARS-CoV-2 | Phase 1 | 2020-12-04 |
| Completed | Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects Healthy | Phase 1 | 2020-06-01 |
| Completed | Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults Healthy | Phase 1 | 2017-03-20 |
| Completed | Japanese Pediatric H5N1 Vaccine Study Influenza | Phase 3 | 2013-08-01 |
| Completed | H5N1 Vaccine Study in Japanese Elderly Population Aged 65 Years and Older Influenza | Phase 3 | 2013-03-01 |
| Completed | Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) Influenza | Phase 3 | 2013-01-01 |
| Completed | Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 Prophylaxis of Ross River Virus Infection | Phase 3 | 2012-07-01 |
| Completed | Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder Post Traumatic Stress Disorder | N/A | 2012-06-01 |
| Completed | H5N1 Vaccine Study in Japanese Adults H5N1 Influenza | Phase 2 / Phase 3 | 2011-06-01 |
| Completed | Ross River Virus (RRV) Vaccine Study Prophylaxis of Ross River Virus Infection | Phase 3 | 2011-04-01 |
| Completed | Reverse Genetic H9N2 Influenza Vaccine Study in Adults Influenza | Phase 1 / Phase 2 | 2011-03-01 |
| Completed | Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine | Phase 1 | 2010-09-01 |
| Completed | Yearly Strain Variation Study, 2010/2011 Influenza, Seasonal Influenza | Phase 3 | 2010-07-01 |
| Completed | Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine Influenza | Phase 3 | 2010-02-01 |
| Completed | Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infant Influenza, Avian | Phase 1 / Phase 2 | 2009-12-01 |
| Completed | Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine Influenza, Pandemic Influenza | — | 2009-11-01 |
| Completed | A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents Influenza, Pandemic Influenza | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | A/H1N1 Immunogenicity and Safety in Adults Influenza, Pandemic Influenza | Phase 1 / Phase 2 | 2009-08-01 |
| Completed | Yearly Strain Variation Study, 2009/2010 Influenza, Seasonal Influenza | Phase 3 | 2009-06-01 |
| Completed | Immunogenicity and Safety Study of a Single Prime-Boost Vaccination Schedule With a H5N1 Influenza Vaccine in Influenza, Avian Influenza | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture C Influenza | Phase 3 | 2008-12-01 |
| Completed | Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Influenza | Phase 3 | 2008-11-01 |
| Completed | Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups Influenza | Phase 3 | 2008-08-01 |
| Completed | Phase 1 Study of a H5N1 Influenza Vaccine (Reverse Genetic Reassortant) Influenza, Pandemic Influenza | Phase 1 | 2008-07-01 |
| Completed | Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine Ross River Virus Disease (RRVD) | Phase 1 / Phase 2 | 2008-06-01 |
| Completed | Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influe Influenza | Phase 3 | 2007-11-01 |
| Completed | Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Influenza | Phase 2 | 2007-09-01 |
| Completed | Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Influenza | Phase 1 / Phase 2 | 2007-07-01 |
| Completed | Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Deri Influenza | Phase 3 | 2007-04-01 |
| Completed | Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) Influenza | Phase 1 / Phase 2 | 2007-01-01 |
| Completed | Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) Influenza | Phase 1 / Phase 2 | 2006-06-01 |
| Completed | Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) Influenza | Phase 1 / Phase 2 | 2006-01-01 |
| Completed | Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Man Influenza | Phase 2 / Phase 3 | 2004-11-01 |
| Completed | Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With Influenza | Phase 2 / Phase 3 | 2003-12-01 |